Latest Listings And Ipos News

Fluence has already exceeded its full-year 2025 EBITDA after nine months of 2026, but delayed customer decisions have cut order intake and pushed operating cash flow into the red. The ASX-listed water treatment group is betting on a stronger fourth quarter to convert its improving margins into cash and backlog.

Dimerix has more than doubled its cash balance after an Everest Medicines licensing payment and a drawdown from a secured funding facility. The ASX-listed biotech is also advancing its fully recruited Phase 3 trial while preparing a second kidney drug for Phase 2 testing.

Alcidion has started FY27 with contracted revenue up 38% to $50.0 million, while a major UK expansion and new patient administration product widen its growth case. The company has also reaffirmed that FY27 revenue and underlying EBITDA will exceed FY26, but its capital plan now has several competing demands.

Hawsons Iron has confirmed a 69.3% Fe magnetite concentrate in bulk testwork and identified a possible second iron product from the processing waste stream. The gains arrive alongside a $1.23 million capital raise, but quarter-end cash covered only 1.22 quarters of reported outgoings before a later tax incentive receipt.

Po Valley Energy delivered record September-quarter revenue and €2.52 million of net production cash flow, despite moderating Podere Maiar-1 output to manage rising formation water. The ASX-listed gas producer is also moving its next Italian drilling programme through environmental approvals while weighing how to fund development without dilution.

Pancontinental Energy has expanded the prospective resource inventory at its offshore Namibia project while advancing seismic reprocessing and farm-out talks. Yet the annual report flags a material uncertainty over the company’s ability to continue funding exploration without new capital or a partner.

Great Boulder Resources has completed more than 57,000 metres of drilling across Peak Hill and Side Well during the September quarter, with high-grade results supporting potential resource growth. The ASX-listed explorer ended the period with A$12.3 million in cash and no debt as it works towards a Peak Hill resource update by year-end.

Immutep has identified structural differences between the efti used in its failed TACTI-004 Phase III trial and batches used in earlier successful studies, prompting a new 200 L manufacturing run. The biotech is narrowing efti’s future development focus while elevating autoimmune candidate IMP761 to co-priority status.

Ragusa Minerals has identified 14 priority drill targets at its Black Rock manganese prospect in Arizona, opening the next stage of its maiden resource campaign. The exploration milestone arrives alongside a stark funding warning: the company held about A$65,000 in cash at quarter-end, equivalent to 0.38 quarters of funding at reported outflow rates.

Freightways delivered double-digit growth across revenue and profit in FY26, but elevated fuel prices and weaker premium-service demand are now squeezing margins. The NZX and ASX-listed courier group expects volumes to remain subdued until fuel costs ease sustainably.

AoFrio’s nine-month revenue fell 20% to NZ$50.3 million as motor sales plunged, while EBITDA dropped to NZ$0.8 million. The NZX-listed refrigeration technology company is relying on new US bottler orders, Food Retail expansion and its IoT platform to support a more profitable 2027.

Singapore-based Navaa Holdings has agreed to invest an initial $3 million in WasteCo, with a further $6.07 million potentially giving it 50.1% of the voting rights. The larger investment still depends on due diligence and shareholder approval.